friends of FSH Research


Search News Items

aTyr Pharma Reports Promising Signals with Resolaris

Press release from aTyr
Reprinted with permission Contact: Mark Johnson Sr. Director, Investor Relations +1-858-223-1163 aTyr Pharma Reports Promising Signals of Clinical …

Acceleron to Webcast Overview of ACE-083 Phase 2 Trial

Webcast to be held Oct 28, 2016 at 10:00 a.m. EDT with Dr. Statland. Archive available on website.
An archive of the webcast can be accessed on the Company's website. Acceleron Pharma Inc. will host an educational webinar on FSHD and the Company's Phase 2 clinical trial of A…